Multiple sclerosis is a chronic inflammatory demyelinating disease of the central nervous system. Diffusion tensor magnetic resonance imaging (DTI) can yield important information on the in vivo pathological processes affecting water diffusion. The aim of this study was to quantitatively define water diffusion in normal-appearing white matter (NAWM) distant from the plaque, in the plaque, and around the plaque, and to investigate the correlation of these changes with clinical disability. Conventional MRI and DTI scans were conducted in 30 patients with MS and 15 healthy individuals. Fractional anisotropy maps and visible diffusion coefficients were created and integrated with T2-weighted images. Regions of interest (ROIs) were placed on the plaques on the same side, white matter around the plaques and NAWM on the opposite side. Only the white matter of healthy individuals in the control group, and FA and ADC values were obtained for comparison. The highest FA and lowest ADC were detected in the control group at the periventricular region, cerebellar peduncle and at all ROIs irrespective of location. There was a significant difference in comparison to the control group at all ROIs in patients with MS (p < 0.001 for all comparisons). No significant correlation between diffusion parameters and expanded disability state scale (EDSS) scores was found in patients with MS. DTI may provide more accurate information on the damage due to the illness, compared to T2A sequences, but this damage may not be correlated with the clinical disability measured by EDSS score.
McDonaldWICompstonAEdanG. Recommended diagnostic criteria for multiple sclerosis. Ann Neurol. 2001; 50: 121–127.
5.
Wayne MooreGR. MRI-clinical correlations: more than inflammation alone-What can MRI contribute to improve the understanding of pathological processes in MS?J Neurol Sci.2003; 206: 175–179.
6.
BrexPACiceralliOO'RiordanJI. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med.2002; 346: 158–164.
7.
KappoLMoeriDRadueEW. Predictive value of gadolinium-enhancent magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta analysis Group. Lancet. 1999; 353: 964–969.
8.
GeYLawMGrossmanRI. Applications of diffusion tensor MR imaging in multiple sclerosis. Ann N Y Acad Sci.2005; 1064: 202–219.
9.
SarchielliPPresciuttiOPelliccioliGP. Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients. Brain. 1999; 122: 513–521.
10.
FreedmanMS. Multiple Sclerosis and Demyelinating Diseases Advances in Neurology. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 111–185.
11.
FilippiMCampiADoussetV. A magnetization transfer imaging study of normal appearing white matter in multiple sclerosis. Neurology. 1995; 45: 478–82.
12.
MillerDHThompsonAJFilippiM. Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. J Neurol. 2003; 250: 1407–1419.
13.
LiDKZhaoGPatyDW. T2 hiperintensities: findings and significance. Neuroimaging Clin North Am.2000; 10: 717–738.
14.
BarkhofFBruckWDe GrootJG. Remyelinating lesions in Multiple Sclerosis; magnetic resonance image appearance. Arch Neurol. 2003; 60: 1073–1081.
15.
BakshiRAriyaratanaSBenedictRH. Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. Arch Neurol. 2001; 58: 742–748.
16.
SchreiberKSorensenPSKoch-HenriksenN. Correlations of brain MRI parameters to disability in multiple sclerosis. Acta Neurol Scand. 2001; 104: 24–30.
17.
BarkhofF. MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS). Mult Scler. 1999; 5: 283–286.
18.
De GrootJGBergersEKamphorstW. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain. 2001; 124: 1635–1645.
19.
LucchinettiCFParisiJBruckW. The patology of Multiple Sclerosis. In: WolinskyJS. Neurologıc Clinics. Philadelphia: Elsevier Inc; 2005. p. 77–105.
20.
PittockSJLucchinettiCF. The pathology of MS. New insights and potential clinical applications. The Neurologist. 2007; 13 (2): 45–56.
21.
MoriS. Methods and Applications of Diffusion Tensor Imaging. In: TogaAWMazziottaJC (eds.) Brain Mapping: The Methods. 2nd edition. USA: Elsevier Science; 2002. p. 379–397.
22.
HagmannPJonassonLMaederP. Understanding Diffusion MR Imaging Techniques: From Scalar Diffusion-Weighted Imaging to Diffusion Tensor Imaging and Beyond. Radiographics. 2006; 26: 205–223.
23.
MukherjeePBermanJIChungSW. Diffusion Tensor MR Imaging and Fiber Tractography: Theoretic Underpinnings. Am J Neuroradiol. 2008; 29: 632–641.
24.
FillerA. Magnetic resonance neurography and diffusion tensor imaging: origins, history, and clinical impact of the first 50,000 cases with an assessment of efficacy and utility in a prospective 5000-patient study group. Neurosurgery. 2009; 65 (4 Suppl): A29–A43.
25.
KingsleyPB. Introduction to Diffusion Tensor Imaging Mathematics. Concepts in Magnetic Resonance Part A.2006; 2: 123–154.
26.
PadovaniABorroniBBrambatiSM. Diffusion tensor imaging and voxelbased morphometry study in early progressive supranuclear palsy. J Neurol Neurosurg Psychiatry. 2006; 77: 457–463.
27.
WerringDJClarkCABarkerGJ. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology. 1999; 52: 1626–1632.
28.
VrenkenHPouwelsPJGeurtsJJ. Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging. 2006; 23: 628–636.
29.
DrooganAGClarkCAWerringDJ. Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion weighted imaging. Magn Reson Imaging. 1999; 17: 653–661.
30.
SundgrenPCDongQGomez-HassanD. Diffusion Tensor Imaging of the Brain: Review of Clinical Applications. Neuroradiology. 2004; 46: 339–350.
31.
BammerRAugustinMStrasser-FuchsS. Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis. Magn Reson Med.2000; 44: 583–591.
32.
Castriota-ScanderbegAFasanoFHagbergG. Coefficient D(av) is more sensitive than fractional anisotropy in monitoring progression of irreversible tissue damage in focal nonactive multiple sclerosis lesions. Am J Neuroradiol. 2003; 24: 663–670.
LarssonHBThomsenCFrederiksenJ. In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis. Magn Reson Imaging. 1992; 10: 7–12.
35.
FilippiMIannucciGCercignaniM. A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo plannar imaging. Arch Neurol. 2000; 57: 1017–1021.
36.
BasserPJPierpaoliC. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B.1996; 111 (3): 209–219.
37.
CiccarelliOWerringDJWheeler-KingshottCAM. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology. 2001; 56: 926–933.
38.
RoychowdhurySMaldjianJAGrossmanRI. Multiple sclerosis: comparison of trace apparent diffusion coefficients with MR enhancement pattern of lesions. Am J Neuroradiol. 2000; 21: 869–874.
39.
DavieCABarkerGJThompsonAJ. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1997; 63: 736–742.
40.
RevelM. Interferon-B in the treatment of relapsing-remitting multiple sclerosis. Pharmacol Ther. 2003; 100: 49–62.
41.
KornekBStorchMKWeissertR. Multiple Sclerosis and cronic autoimmune encephalomyelitis: a comparative quantative study of axonal injury in active, inactive and remyelinated lesions. Am J Pathol. 2000; 157: 267–276.
42.
GuoACMacFallJRProvenzaleJM. Multiple sclerosis: Diffusion tensor magnetic resonance imaging of normal appearing white matter. Radiology. 2002; 729–735.
43.
McDonaldWIMillerDHBarnesD. The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol. 1992; 18: 319–334.
44.
ArnoldDLMatthewsPMFrancisGS. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol. 1992; 31: 235–241.
45.
LassmannHBrückWLucchinettiCF. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007; 17 (2): 210–218.
46.
CercignaniMIannucciGRoccaMA. 2000. Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI. Neurology. 2000; 54 (5): 1139–1144.
47.
GuoACMacFallJRProvenzaleJM. Multiple sclerosis: diffusion tensor MR imaging for evaluation of normal-appearing white matter. Radiology. 2001; 222 (3): 729–736.
48.
TievskyALPtakTFarkasJ. Investigation af apparent diffusion coefficient and diffusion tensor anisotrophy in acute and cronic multiple sclerosis lesions. Am J Neuroradiol. 1999; 20: 1491–1499.
49.
CeccarelliARoccaMAFaliniA. Normal-appearing white and grey matter damage in MS. A volumetric and diffusion tensor MRI study at 3.0 Tesla. J Neurol. 2007; 254 (4): 513–518. Epub 2007.
50.
GeYTuviaKLawM. Corticospinal tract degeneration in brainstem in patients with multiple sclerosis: evaluation with diffusion tensor tractography. In Proceedings: Int Soc. Magn Reson Med (ISMRM), Miami, 2005.
51.
CampiAStaempfliPJaermannT. Preliminary study with high resolution SENSE DTI at 3 T: DTI and fiber tracking study in multiple sclerosis. In: Proceedings of the 42nd Annual Meeting of the American Society of Neuroradiology, Seattle, 2005. p. 7.
